Clinical Trial

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
A Phase 3 multi-institutional study for treatment of children with newly diagnosed hepatoblastoma using a modified Paediatric Hepatic International Tumour Trial (PHITT) strategy incorporating a randomized assessment of sodium thiosulfate as auditory protection for children with localized disease, and response adapted therapy for patients with metastatic disease
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2020-07-15; most recent amendment 2026-04-28.
Status change: Not Yet Recruiting → Recruiting 2021-03-17
Status change: Recruiting → Not Yet Recruiting 2021-02-11
Trial Details
NCT Number NCT04478292
Lead Sponsor Shanghai Children's Medical Center
Collaborators: Shanghai Children's Hospital
Conditions Hepatoblastoma
Enrollment 330 participants
Start Date 2021-03-01
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-04